Know Our

---

Other Documents

• Intimation of Closure of Trading Window
• Regulation23(9) disclosure on Related Party Transactions
• Annual Audited Financial Results for the year ended March 31, 2019
• Amendment to Regulation 40
• Intimation letter for the quarter ended 30 September, 2018
• Intimation of Change in Corporate Office Address
• Intimation Meeting for Quarter1 Results 14-Aug-2018
• Resignation of Mrs. Savita Gowda & Mr. Lalit Misra
• Appointment of Mr. Kaushik Banerjee as Chief Executive Officer
• Board Meeting for Q4 Results_30.05.2018
• Appointment of Nodal Officer for IEPF process
• Notice For Adoption of Financial Results For the Quarter Ended June, September & December 2017
• Unpaid Dividend
• Filling Under Regulation 13
• AGM Results- REGULATION 44(3)
• Notice Transfer of Equity Shares of the Company to Investor(IEPF)
• Extension Letter for CIRP Period
• Letter for extension of AGM Letter of Resignation Mr. Harish & Dr. Nivedita
• 27th Annual General Meeting
• 4th Quarter Notice for Financial Results 31 March 2017
• 3rd Quarter Board Meeting
• 2nd Quarter Board Meeting
• 1st Quarter Board Meeting
• Letter of USFDA Approval for API Plant BSE
• Letter of USFDA Approval for API Plant NSE
• Public announcment
• NCLT-Regulation 13-List of creditors
• Policy Document